These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 2200727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
    Demant T, Gaw A, Watts GF, Durrington P, Buckley B, Imrie CW, Wilson C, Packard CJ, Shepherd J.
    J Lipid Res; 1993 Jan; 34(1):147-56. PubMed ID: 8445339
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of simvastatin on apoB metabolism and LDL subfraction distribution.
    Gaw A, Packard CJ, Murray EF, Lindsay GM, Griffin BA, Caslake MJ, Vallance BD, Lorimer AR, Shepherd J.
    Arterioscler Thromb; 1993 Feb; 13(2):170-89. PubMed ID: 8427854
    [Abstract] [Full Text] [Related]

  • 6. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism.
    Packard CJ, Gaw A, Demant T, Shepherd J.
    J Lipid Res; 1995 Jan; 36(1):172-87. PubMed ID: 7706942
    [Abstract] [Full Text] [Related]

  • 7. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
    Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Vergès B.
    Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
    [Abstract] [Full Text] [Related]

  • 8. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR, Björnson E, Kahri J, Söderlund S, Matikainen N, Porthan K, Ainola M, Hakkarainen A, Lundbom N, Fermanelli V, Fuchs J, Thorsell A, Kronenberg F, Andersson L, Adiels M, Packard CJ, Borén J.
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [Abstract] [Full Text] [Related]

  • 9. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.
    Barrett PH, Baker N, Nestel PJ.
    J Lipid Res; 1991 May; 32(5):743-62. PubMed ID: 2072038
    [Abstract] [Full Text] [Related]

  • 10. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
    Demant T, Bedford D, Packard CJ, Shepherd J.
    J Clin Invest; 1991 Nov; 88(5):1490-501. PubMed ID: 1939641
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
    Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, Bedynek A, Shepherd J, Seidel D.
    J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
    [Abstract] [Full Text] [Related]

  • 12. Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism.
    Packard CJ, Shepherd J, Lindsay GM, Gaw A, Taskinen MR.
    J Clin Endocrinol Metab; 1993 May; 76(5):1209-16. PubMed ID: 8496312
    [Abstract] [Full Text] [Related]

  • 13. Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria.
    Warwick GL, Packard CJ, Demant T, Bedford DK, Boulton-Jones JM, Shepherd J.
    Kidney Int; 1991 Jul; 40(1):129-38. PubMed ID: 1921148
    [Abstract] [Full Text] [Related]

  • 14. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
    Taskinen MR, Matikainen N, Björnson E, Söderlund S, Inkeri J, Hakkarainen A, Parviainen H, Sihlbom C, Thorsell A, Andersson L, Adiels M, Packard CJ, Borén J.
    Diabetologia; 2023 Dec; 66(12):2307-2319. PubMed ID: 37775612
    [Abstract] [Full Text] [Related]

  • 15. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.
    Pont F, Duvillard L, Florentin E, Gambert P, Vergès B.
    Arterioscler Thromb Vasc Biol; 2002 Oct 01; 22(10):1726-32. PubMed ID: 12377756
    [Abstract] [Full Text] [Related]

  • 16. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF, Stewart G, Bedford D, Stewart JP, Rogers E, Shepherd J, Packard CJ, Caslake MJ.
    Atherosclerosis; 2002 Sep 01; 164(1):129-45. PubMed ID: 12119202
    [Abstract] [Full Text] [Related]

  • 17. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans.
    Anber V, Millar JS, McConnell M, Shepherd J, Packard CJ.
    Arterioscler Thromb Vasc Biol; 1997 Nov 01; 17(11):2507-14. PubMed ID: 9409221
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations.
    Ooi EM, Russell BS, Olson E, Sun SZ, Diffenderfer MR, Lichtenstein AH, Keilson L, Barrett PH, Schaefer EJ, Sprecher DL.
    Arterioscler Thromb Vasc Biol; 2012 Feb 01; 32(2):459-66. PubMed ID: 22095987
    [Abstract] [Full Text] [Related]

  • 19. Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.
    Abbott WG, Swinburn B, Ruotolo G, Hara H, Patti L, Harper I, Grundy SM, Howard BV.
    J Clin Invest; 1990 Aug 01; 86(2):642-50. PubMed ID: 2200808
    [Abstract] [Full Text] [Related]

  • 20. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.
    Diabetes; 2003 Mar 01; 52(3):803-11. PubMed ID: 12606523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.